Nxera Pharma collaborates with Centessa Pharmaceuticals to develop a novel orexin receptor 2 agonist, resulting in milestone payments.
1 report, 1 independent
Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nxera Pharma collaborates with Centessa Pharmaceuticals to develop a novel orexin receptor 2 agonist, resulting in milestone payments.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nxera Pharma
company in Tokyo, Japan
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyCentessa Pharmaceuticals Advances Neurological Drug ORX142 to Clinical Trials Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best low priced pharma stocks to buy now. On July 4, Nxera Pharma Co